How Do Insurers Evaluate Recurring Ovarian Cysts During Policy Issuance?

Insurers evaluate recurring ovarian cysts as pre-existing diseases. Underwriting team assess risk by looking at the cyst’s type (eg, simple, endometriotic, dermoid), size, symptoms and potential for malignancy using ultrasound imaging and tumour marker (CA-125) blood tests. Policyholders usually face waiting periods, premium loadings, or exclusions. To arrive at a risk assessment, health insurance underwriters generally prefer the following specific evaluation criteria:

• Medical Declaration: You must not hide the history of recurring cysts or PCOS/ PCOD in the initial application form. Not revealing this condition may result in claim denials later.


• Diagnostic Review: Underwriters will request the recent pelvic examination notes, gynaecological consultations and ultrasound scale results to determine the nature of the cysts.


• Cancer Screening: The primary goal of the medical review is to ensure the recurring cysts are functional or benign and do not indicate ovarian cancer.


• Underwriting Decisions: If accepted, the insurance provider will typically categorise the condition as a pre-existing disease, which means related hospitalisation

Waiting Period and Coverage

• Standard Waiting Period: Pre-existing diseases like recurring ovarian cysts or PCOS generally carry a standard waiting period of 2 to 4 years (depending on the specific policy chosen) before treatment costs are covered.


• Waiting Period Reduction: For specific plans, you can select a "Buy-back PED" add-on. This rider allows you to reduce the waiting period for pre-existing diseases from 36 months to 12 months.

Significance of Health Insurance for Treatment of Cysts

Health insurance plays a significant role in the diagnosis and treatment of cysts. It helps cover the cost of expensive diagnostic tests like ultrasounds, CT scans, and MRIs. In addition, health insurance can provide treatment coverage such as medication, drainage procedures, or surgery. Given that some cysts, especially ovarian cysts, may require ongoing monitoring and management, having comprehensive health insurance is crucial for ensuring access to the necessary care without financial burden. While many cysts are benign and may not require treatment, others can result in symptoms that need medical intervention.

Understanding the symptoms, causes and treatment options for cysts is crucial for managing them effectively. Regular screenings and maintaining good health practices can help in early detection and prevention. Additionally, having an insurance policy is essential for covering expenses associated with the diagnosis and treatment of cysts, ensuring that you receive the best possible medical attention without paying upfront.